nodes	percent_of_prediction	percent_of_DWPC	metapath
Bevantolol—ADRB1—type 1 diabetes mellitus	0.97	1	CbGaD
Bevantolol—Verapamil—CACNA1G—type 1 diabetes mellitus	0.00217	0.257	CrCbGaD
Bevantolol—Verapamil—KCNJ11—type 1 diabetes mellitus	0.0013	0.154	CrCbGaD
Bevantolol—Esmolol—ADRB1—type 1 diabetes mellitus	0.0013	0.154	CrCbGaD
Bevantolol—Bisoprolol—ADRB1—type 1 diabetes mellitus	0.0011	0.131	CrCbGaD
Bevantolol—Metoprolol—ADRB1—type 1 diabetes mellitus	0.00088	0.105	CrCbGaD
Bevantolol—Propafenone—ADRB1—type 1 diabetes mellitus	0.000649	0.0771	CrCbGaD
Bevantolol—Carvedilol—ADRB1—type 1 diabetes mellitus	0.000584	0.0694	CrCbGaD
Bevantolol—Propranolol—ADRB1—type 1 diabetes mellitus	0.000444	0.0528	CrCbGaD
Bevantolol—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB1—type 1 diabetes mellitus	0.000118	0.00556	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.000117	0.00549	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.000117	0.00549	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.000115	0.00544	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.000114	0.00538	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.000114	0.00538	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00011	0.00517	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR3—type 1 diabetes mellitus	0.000108	0.00507	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.000107	0.00505	CbGpPWpGaD
Bevantolol—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.000104	0.00488	CbGpPWpGaD
Bevantolol—ADRA1A—Calcium Regulation in the Cardiac Cell—PRKCQ—type 1 diabetes mellitus	0.000102	0.00479	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	9.55e-05	0.0045	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	9.44e-05	0.00445	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	9.44e-05	0.00445	CbGpPWpGaD
Bevantolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	9.19e-05	0.00433	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—GAL—type 1 diabetes mellitus	8.98e-05	0.00423	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—CCL11—type 1 diabetes mellitus	8.88e-05	0.00418	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—CCL20—type 1 diabetes mellitus	8.88e-05	0.00418	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	8.88e-05	0.00418	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (q) signalling events—GCG—type 1 diabetes mellitus	8.81e-05	0.00415	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—GAL—type 1 diabetes mellitus	8.79e-05	0.00414	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—CCL11—type 1 diabetes mellitus	8.69e-05	0.00409	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—CCL20—type 1 diabetes mellitus	8.69e-05	0.00409	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (q) signalling events—PRKCQ—type 1 diabetes mellitus	8.48e-05	0.00399	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	8.35e-05	0.00393	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	8.17e-05	0.00385	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	8.09e-05	0.00381	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	7.91e-05	0.00373	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 1 diabetes mellitus	7.88e-05	0.00371	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	7.88e-05	0.00371	CbGpPWpGaD
Bevantolol—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	7.6e-05	0.00358	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—type 1 diabetes mellitus	7.58e-05	0.00357	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—GAL—type 1 diabetes mellitus	7.27e-05	0.00342	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—CCL20—type 1 diabetes mellitus	7.19e-05	0.00339	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—CCL11—type 1 diabetes mellitus	7.19e-05	0.00339	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	7.01e-05	0.0033	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—IAPP—type 1 diabetes mellitus	6.86e-05	0.00323	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	6.76e-05	0.00318	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	6.72e-05	0.00316	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	6.57e-05	0.0031	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	6.54e-05	0.00308	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	6.51e-05	0.00307	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—SST—type 1 diabetes mellitus	6.16e-05	0.0029	CbGpPWpGaD
Bevantolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	6.08e-05	0.00286	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—SST—type 1 diabetes mellitus	6.02e-05	0.00284	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	6e-05	0.00282	CbGpPWpGaD
Bevantolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	5.95e-05	0.0028	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—IAPP—type 1 diabetes mellitus	5.68e-05	0.00267	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—GCG—type 1 diabetes mellitus	5.49e-05	0.00259	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	5.44e-05	0.00256	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—GCG—type 1 diabetes mellitus	5.37e-05	0.00253	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	5.21e-05	0.00245	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	5.12e-05	0.00241	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	5.1e-05	0.0024	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	5.08e-05	0.00239	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	5.02e-05	0.00236	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	5.01e-05	0.00236	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—SST—type 1 diabetes mellitus	4.98e-05	0.00235	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—GAL—type 1 diabetes mellitus	4.97e-05	0.00234	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	4.96e-05	0.00234	CbGpPWpGaD
Bevantolol—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	4.92e-05	0.00232	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	4.91e-05	0.00231	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	4.72e-05	0.00222	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	4.62e-05	0.00217	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—GAL—type 1 diabetes mellitus	4.61e-05	0.00217	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	4.56e-05	0.00215	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	4.56e-05	0.00215	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—GAL—type 1 diabetes mellitus	4.51e-05	0.00212	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CCL11—type 1 diabetes mellitus	4.46e-05	0.0021	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CCL20—type 1 diabetes mellitus	4.46e-05	0.0021	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—GCG—type 1 diabetes mellitus	4.44e-05	0.00209	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	4.29e-05	0.00202	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	4.24e-05	0.002	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	4.22e-05	0.00199	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	4.19e-05	0.00197	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	4.15e-05	0.00195	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	4.14e-05	0.00195	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—GAL—type 1 diabetes mellitus	4.11e-05	0.00193	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	4.06e-05	0.00191	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	3.97e-05	0.00187	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	3.96e-05	0.00187	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	3.95e-05	0.00186	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—CCR5—type 1 diabetes mellitus	3.88e-05	0.00183	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	3.88e-05	0.00183	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	3.85e-05	0.00181	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	3.82e-05	0.0018	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	3.76e-05	0.00177	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—GAL—type 1 diabetes mellitus	3.73e-05	0.00176	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	3.69e-05	0.00174	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	3.69e-05	0.00174	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	3.6e-05	0.0017	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—IAPP—type 1 diabetes mellitus	3.52e-05	0.00166	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—SST—type 1 diabetes mellitus	3.48e-05	0.00164	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	3.47e-05	0.00163	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	3.43e-05	0.00161	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—SST—type 1 diabetes mellitus	3.4e-05	0.0016	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	3.39e-05	0.0016	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—CCR5—type 1 diabetes mellitus	3.21e-05	0.00151	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	3.21e-05	0.00151	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—SST—type 1 diabetes mellitus	3.16e-05	0.00149	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	3.11e-05	0.00147	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	3.1e-05	0.00146	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—SST—type 1 diabetes mellitus	3.09e-05	0.00146	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	3.08e-05	0.00145	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—GCG—type 1 diabetes mellitus	3.03e-05	0.00143	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	2.99e-05	0.00141	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	2.92e-05	0.00138	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	2.91e-05	0.00137	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	2.9e-05	0.00137	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	2.89e-05	0.00136	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	2.84e-05	0.00134	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	2.83e-05	0.00133	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—GCG—type 1 diabetes mellitus	2.82e-05	0.00133	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—SST—type 1 diabetes mellitus	2.82e-05	0.00133	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	2.8e-05	0.00132	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—GCG—type 1 diabetes mellitus	2.76e-05	0.0013	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GAL—type 1 diabetes mellitus	2.72e-05	0.00128	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	2.71e-05	0.00128	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCL20—type 1 diabetes mellitus	2.69e-05	0.00127	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCL11—type 1 diabetes mellitus	2.69e-05	0.00127	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GAL—type 1 diabetes mellitus	2.66e-05	0.00125	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	2.65e-05	0.00125	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCL20—type 1 diabetes mellitus	2.63e-05	0.00124	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCL11—type 1 diabetes mellitus	2.63e-05	0.00124	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	2.63e-05	0.00124	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	2.63e-05	0.00124	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—VAV1—type 1 diabetes mellitus	2.58e-05	0.00121	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	2.57e-05	0.00121	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—SST—type 1 diabetes mellitus	2.56e-05	0.0012	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	2.55e-05	0.0012	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	2.53e-05	0.00119	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	2.52e-05	0.00119	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	2.51e-05	0.00118	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CHRM2—type 1 diabetes mellitus	2.48e-05	0.00117	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	2.42e-05	0.00114	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	2.35e-05	0.00111	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	2.34e-05	0.0011	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—GCG—type 1 diabetes mellitus	2.28e-05	0.00107	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.27e-05	0.00107	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.24e-05	0.00106	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.22e-05	0.00105	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.21e-05	0.00104	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GAL—type 1 diabetes mellitus	2.2e-05	0.00104	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	2.19e-05	0.00103	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.19e-05	0.00103	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCL11—type 1 diabetes mellitus	2.18e-05	0.00103	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCL20—type 1 diabetes mellitus	2.18e-05	0.00103	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.16e-05	0.00102	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.14e-05	0.00101	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	2.13e-05	0.001	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.13e-05	0.001	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.13e-05	0.001	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	2.12e-05	0.001	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.09e-05	0.000986	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.08e-05	0.00098	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.08e-05	0.00098	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	2.05e-05	0.000965	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.04e-05	0.000959	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.01e-05	0.000945	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.99e-05	0.000938	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.96e-05	0.000925	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	1.93e-05	0.000911	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SST—type 1 diabetes mellitus	1.87e-05	0.000879	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	1.84e-05	0.000866	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SST—type 1 diabetes mellitus	1.83e-05	0.00086	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.82e-05	0.000856	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	1.81e-05	0.000855	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	1.79e-05	0.000842	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.73e-05	0.000815	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.72e-05	0.00081	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.72e-05	0.00081	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GCG—type 1 diabetes mellitus	1.66e-05	0.000784	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.65e-05	0.000776	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GCG—type 1 diabetes mellitus	1.63e-05	0.000767	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.62e-05	0.000765	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.6e-05	0.000754	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.57e-05	0.000738	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.56e-05	0.000733	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.55e-05	0.000731	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.52e-05	0.000717	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.52e-05	0.000715	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SST—type 1 diabetes mellitus	1.51e-05	0.000711	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.5e-05	0.000708	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.41e-05	0.000666	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.41e-05	0.000663	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.38e-05	0.000651	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.38e-05	0.000649	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.36e-05	0.000639	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GCG—type 1 diabetes mellitus	1.35e-05	0.000634	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CD86—type 1 diabetes mellitus	1.33e-05	0.000625	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.3e-05	0.00061	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.3e-05	0.00061	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.29e-05	0.000606	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.27e-05	0.000597	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.26e-05	0.000593	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.26e-05	0.000593	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.26e-05	0.000591	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.22e-05	0.000576	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.2e-05	0.000567	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.2e-05	0.000564	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.19e-05	0.000558	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.18e-05	0.000554	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.18e-05	0.000554	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.16e-05	0.000546	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.15e-05	0.000542	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.14e-05	0.000539	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.14e-05	0.000537	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CD86—type 1 diabetes mellitus	1.1e-05	0.000517	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.05e-05	0.000494	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.04e-05	0.000491	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.9e-06	0.000466	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CD80—type 1 diabetes mellitus	9.9e-06	0.000466	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.73e-06	0.000458	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CD80—type 1 diabetes mellitus	9.68e-06	0.000456	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.59e-06	0.000452	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.52e-06	0.000448	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—INS—type 1 diabetes mellitus	9.35e-06	0.00044	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—INS—type 1 diabetes mellitus	9.15e-06	0.000431	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.04e-06	0.000426	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9e-06	0.000424	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.85e-06	0.000417	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.8e-06	0.000415	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.35e-06	0.000393	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.2e-06	0.000386	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.17e-06	0.000385	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.02e-06	0.000378	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	8.01e-06	0.000377	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	7.57e-06	0.000356	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.32e-06	0.000345	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.28e-06	0.000343	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.96e-06	0.000328	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IL2—type 1 diabetes mellitus	6.95e-06	0.000327	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.92e-06	0.000326	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.81e-06	0.000321	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IL2—type 1 diabetes mellitus	6.8e-06	0.00032	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.77e-06	0.000319	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.76e-06	0.000318	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.63e-06	0.000312	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.85e-06	0.000275	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.72e-06	0.000269	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.63e-06	0.000265	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	5.62e-06	0.000265	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.6e-06	0.000264	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.32e-06	0.00025	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.2e-06	0.000245	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.73e-06	0.000223	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.3e-06	0.000203	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IL6—type 1 diabetes mellitus	4.09e-06	0.000192	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IL6—type 1 diabetes mellitus	4e-06	0.000188	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.31e-06	0.000156	CbGpPWpGaD
